Boxer Capital, LLC G1 Therapeutics, Inc. Transaction History

Boxer Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$35.06 - $51.17 $23.1 Million - $33.8 Million	-660,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$19.05 - $41.76 $587,140 - $1.29 Million	30,821 Added 4.9%	660,000 $24.5 Million
Q3 2017 Nov 14, 2017	BUY	$12.53 - $27.12 $7.88 Million - $17.1 Million	629,179	629,179 $15.7 Million

101

20.1M

1.87M

1.18M

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Boxer Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Boxer Capital, LLC with notifications on news.